EVFM — Evofem Biosciences Share News
0.000.00%
Last trade - 00:00- $0.83m
- $59.92m
- $20.18m
Brief: Evofem Biosciences Announces Successful Type C Meeting With FDA For STI Prevention Product Candidate
Evofem Biosciences extends sales target of funding pact
Brief: Evofem Biosciences Successfully Extended Cumulative Net Sales Covenant Timing To June 30, 2023
Evofem slumps 16% on bigger loss than expected
U.S. RESEARCH ROUNDUP-Coresite Realty, Hanmi Financial, Y-Mabs Therapeutics
Evofem Biosciences Inc reports results for the quarter ended in September - Earnings Summary
Brief: Evofem Biosciences Reports Q3 Loss Per Share $0.48
Evofem Biosciences Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: Evofem Biosciences Announces Regulatory Submission In Mexico For Its Hormone-Free Contraceptive
U.S. STOCKS ON THE MOVE-Nike, CureVac, Quanterix, Signet Jewelers
Evofem down on preferred shares offering
Brief: Evofem Biosciences Announces $10 Million Registered Direct Offering Of Series B Preferred Stock
Brief: Evofem Biosciences Inc Says It May Consider Available Options To Regain Compliance With Nasdaq Bid Price Requirement
Evofem Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Brief: Evofem Biosciences Posts Q2 Loss Per Share Of $0.27
Brief: Evofem Biosciences Posts Quarterly Loss Per Share Of $0.27
Evofem Biosciences Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: Evofem Biosciences Files For Mixed Shelf Of Upto $150 Mln
Brief: CVI Investments Inc Reports 9.9% Passive Stake In Evofem Biosciences Inc As Of May 18, 2021